Full-Time

Senior Scientist

Protein Chemistry

Posted on 10/25/2024

Pfizer

Pfizer

10,001+ employees

Develops and manufactures biopharmaceutical products

Biotechnology
Healthcare

Compensation Overview

$88.3k - $147.1kAnnually

+ Bonus

Senior

No H1B Sponsorship

Bothell, WA, USA

Relocation support available.

Category
Bioinformatics
Biology Lab & Research
Biology & Biotech
Requirements
  • Ph.D. in Chemistry, Biochemistry, Chemical Biology, or related discipline OR
  • M.S. degree in Chemistry, Biochemistry, Chemical Biology, or related discipline with minimum 7 years experience, with 3 of those years in the biopharmaceutical industry OR
  • B.S. degree in Chemistry, Biochemistry, Chemical Biology, or related discipline with minimum 9 years experience, with 5 of those years in the biopharmaceutical industry
  • Contemporary knowledge of current chemical, protein engineering, and/or bioconjugation concepts and design tools required for biopharmaceutical drug discovery
  • Excellent oral and written communication skills
Responsibilities
  • Conceptualize novel drug linker, bioconjugate, or protein engineering technology opportunities for therapeutic development (ADC or otherwise)
  • Actively design and execute comprehensive experimental plans comprised of in vitro and in vivo experiments that inform and enable project progression
  • Work independently and demonstrate the ability to contribute to projects outside their own expertise
  • Effectively communicate and collaborate across a diverse research department to advance preclinical projects
  • Present data at research project team meetings and seminars to drive recommendations for drug discovery and/or development decisions
  • Contribute to and lead programs by executing lead optimization strategies and driving discovery goals
  • Prepare patent applications and publish impactful research
  • Expand the capabilities of the Antibody Engineering group by implementing new techniques and cutting-edge technologies

Pfizer focuses on creating and producing healthcare products, particularly medicines and vaccines. The company conducts extensive research and development to discover new treatments, which are then manufactured and sold globally. Pfizer's products include vaccines, cancer treatments, and other specialized medications. A key aspect of Pfizer's operations is its partnership with BioNTech to develop a vaccine for COVID-19, showcasing its role in addressing public health challenges. Unlike many competitors, Pfizer emphasizes not only the development of new drugs but also initiatives to ensure that vaccines reach underserved populations. The goal of Pfizer is to enhance global health by expanding its range of effective treatments and vaccines.

Company Stage

IPO

Total Funding

$3.8B

Headquarters

New York City, New York

Founded

1849

Simplify Jobs

Simplify's Take

What believers are saying

  • Pfizer's significant investments in companies like CellCentric and Caribou Biosciences indicate a strong focus on expanding its oncology and cell therapy capabilities.
  • The company's proactive approach in securing investments and partnerships positions it well for future growth and innovation in the biopharmaceutical sector.
  • Pfizer's involvement in funding rounds for promising biotech firms suggests potential for lucrative returns and strategic advancements in healthcare solutions.

What critics are saying

  • The slowdown in demand for COVID-19 vaccines could impact Pfizer's revenue and market perception.
  • Activist investor involvement, such as Starboard Value's $1 billion stake, may lead to pressure for strategic changes that could affect company stability.

What makes Pfizer unique

  • Pfizer's strategic partnerships and investments in innovative biotech companies like Promise Bio and Enara Bio highlight its commitment to cutting-edge research and development.
  • The company's collaboration with BioNTech for the COVID-19 vaccine showcases its ability to rapidly respond to global health crises, setting it apart from many competitors.
  • Pfizer's diverse portfolio, including oncology and specialized medicines, ensures a broad market reach beyond just vaccines.

Help us improve and share your feedback! Did you find this helpful?

INACTIVE